Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : Response Biomedical (V.RBM) -- Ignore unavailable to you. Want to Upgrade?

To: Dick Martin who wrote (328)	9/8/2000 1:46:24 PM
From: Starowl	Read Replies (1) \| Respond to of 655

Dick, nice find. Thanks.

To: Dick Martin who wrote (328)	9/8/2000 3:03:55 PM
From: Rob	Respond to of 655

Thanks Dick. The move toward point-of-care testing will only become stronger as baby boomers age and stretch the capacity (time and $) of the health care systems. The article notes that POC cardiac test growth is estimated at over 39% p.a. I believe the average growth rate worldwide is forecast at over 70% by F & S.- particularly high in countries like China (recall that Response just did a deal with the largest distributor of diagnostics in China) where all but the top tier hospitals cannot afford the expensive lab equipment - but at $2,000 to $3,000 portable reader which is faster and as accurate is not a problem and provides a large leap in the level of care provided. Watch for Response to partner with one or more of the firms on that list - it will be a major marketing partnership that sets the stock price alight. regards R